Page last updated: 2024-11-05

ici 204,219 and Non-alcoholic Fatty Liver Disease

ici 204,219 has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Schierle, S1
Helmstädter, M1
Schmidt, J1
Hartmann, M1
Horz, M1
Kaiser, A1
Weizel, L1
Heitel, P1
Proschak, A1
Hernandez-Olmos, V1
Proschak, E1
Merk, D1

Other Studies

1 other study available for ici 204,219 and Non-alcoholic Fatty Liver Disease

ArticleYear
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.
    ChemMedChem, 2020, 01-07, Volume: 15, Issue:1

    Topics: Binding Sites; Catalytic Domain; Cholesterol 7-alpha-Hydroxylase; Drug Evaluation, Preclinical; Epox

2020